Literature DB >> 17430757

Potential complications associated with the use of biologic agents for psoriasis.

Joshua A Zeichner1, Mark Lebwohl.   

Abstract

The biologic agents are effective drugs to treat psoriasis. They provide physicians with additional options for patients who cannot tolerate traditional therapies or for whom traditional therapies are not sufficient. While these new TNF-alpha inhibitors and anti-T-cell agents have potential complications, they are generally safe with proper monitoring. Both physicians and patients should be aware of the risks involved with each medicine so that the correct drug is chosen to suit each patient.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17430757     DOI: 10.1016/j.det.2007.01.010

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  7 in total

1.  A practical approach to screening psoriasis patients for therapy with biologic agents.

Authors: 
Journal:  J Clin Aesthet Dermatol       Date:  2008-09

2.  A practical approach to monitoring patients on biological agents for the treatment of psoriasis.

Authors:  Jason J Emer; Amylynne Frankel; Joshua A Zeichner
Journal:  J Clin Aesthet Dermatol       Date:  2010-08

Review 3.  A role for TGFbeta signaling in the pathogenesis of psoriasis.

Authors:  Gangwen Han; Cortny A Williams; Kelli Salter; Pamela J Garl; Allen G Li; Xiao-Jing Wang
Journal:  J Invest Dermatol       Date:  2009-08-27       Impact factor: 8.551

Review 4.  Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian Perspective.

Authors:  Lorenzo Mantovani; Massimo Medaglia; Patrizio Piacentini; Marcella Tricca; Gino Antonio Vena; Antonietta Vozza; Gabriella Castellino; Alessandro Roccia
Journal:  Dermatol Ther (Heidelb)       Date:  2016-04-15

5.  Biological drugs targeting the immune response in the therapy of psoriasis.

Authors:  Saveria Pastore; Emanuela Gubinelli; Luca Leoni; Desanka Raskovic; Liudmila Korkina
Journal:  Biologics       Date:  2008-12

6.  Evaluation of renal function in patients with psoriasis using immunobiologicals.

Authors:  Sarah Suyanne Carvalho Melgaço; Geraldo Bezerra da Silva; Amanda Maria Menezes Dantas; Ana Mirella Arcanjo Vasconcelos; Verônica Riquet de Siqueira; Ana Patrícia Freitas Vieira; Elizabeth de Francesco Daher
Journal:  An Bras Dermatol       Date:  2013 Jul-Aug       Impact factor: 1.896

Review 7.  Current knowledge on psoriasis and autoimmune diseases.

Authors:  Nilmarie Ayala-Fontánez; David C Soler; Thomas S McCormick
Journal:  Psoriasis (Auckl)       Date:  2016-02-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.